{"id":119689,"date":"2026-08-18T11:56:05","date_gmt":"2026-08-18T06:26:05","guid":{"rendered":"https:\/\/vajiramandravi.com\/current-affairs\/?p=119689"},"modified":"2026-08-18T11:56:05","modified_gmt":"2026-08-18T06:26:05","slug":"surrogate-advertising-in-india-rules-celebrity-endorsements-and-regulatory-scrutiny","status":"publish","type":"post","link":"https:\/\/vajiramandravi.com\/current-affairs\/surrogate-advertising-in-india-rules-celebrity-endorsements-and-regulatory-scrutiny\/","title":{"rendered":"Surrogate Advertising in India: Rules, Celebrity Endorsements and Regulatory Scrutiny"},"content":{"rendered":"<h2><b>Surrogate Advertising Latest News<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Maharashtra&#8217;s Food and Drug Administration (FDA) issued show-cause notices to actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff, alleging that their advertisement for Vimal Elaichi amounts to surrogate advertising for the banned Vimal Pan Masala brand.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">This marks the first instance of the regulator examining surrogate advertising, even as it intensifies its crackdown on tobacco-containing products.<\/span><\/li>\n<\/ul>\n<h2><b>What Is Surrogate Advertising?<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Surrogate advertising promotes a product under a different, permitted brand name, logo, or visual style.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It is used for goods like alcohol, tobacco, and pan masala, which face advertising bans or restrictions.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The technique keeps the original brand visible in consumers&#8217; minds despite the restriction.<\/span><\/li>\n<\/ul>\n<h2><b>What the FDA Notices Allege<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The FDA claims the Vimal Elaichi ad&#8217;s presentation, dialogue, product name, and market context raise a &#8220;serious question&#8221; over whether it <\/span><b>indirectly promotes<\/b><span style=\"font-weight: 400;\"> Vimal Pan Masala \u2014 a product currently prohibited in Maharashtra.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Maharashtra has banned gutkha and pan masala containing tobacco or nicotine since 2012 under <\/span><b>Section 30(2)(a) of the Food Safety and Standards (FSS) Act, 2006<\/b><span style=\"font-weight: 400;\">.\u00a0<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">This prohibition is renewed annually.\u00a0<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The FDA has invoked:\u00a0<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><b>Section 24<\/b><span style=\"font-weight: 400;\"> of the FSS Act \u2014 restricts misleading and deceptive food advertisements.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><b>Section 53<\/b><span style=\"font-weight: 400;\"> of the FSS Act \u2014 penalty of up to Rs 10 lakh for anyone &#8220;party to the publication&#8221; of a misleading advertisement.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">The Food Safety and Standards (Advertising and Claims) Regulations, 2018.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2><b>What the Actors Have Been Asked to Do<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The FDA has given the actors 15 days to respond with written explanations and has directed them to:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Immediately discontinue participation in and endorsement of the ad, and remove it from their social media handles.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Submit their endorsement contracts, campaign briefs, product information, and payment details.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Disclose details of the due diligence carried out before endorsing the product.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Furnish evidence on whether Vimal Elaichi is an independently sold product or a surrogate\/brand extension of Vimal Pan Masala.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Disclose any material connection with the advertiser or brand owner, as required under the <\/span><strong><a href=\"https:\/\/vajiramandravi.com\/current-affairs\/ccpa-fines-misleading-labels\/\" target=\"_blank\">CCPA<\/a><\/strong><span style=\"font-weight: 400;\"> (Central Consumer Protection authority) Guidelines, 2022.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2><b>The Legal Framework on Misleading and Surrogate Ads<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The Central Consumer Protection Authority (CCPA), established under <\/span><b>Section 10<\/b><span style=\"font-weight: 400;\"> of the <\/span><b>Consumer Protection Act, 2019<\/b><span style=\"font-weight: 400;\">, notified guidelines in 2022 to curb misleading advertisements and endorsements.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Under <\/span><b>Section 2(28)<\/b><span style=\"font-weight: 400;\"> of the Consumer Protection Act, 2019, a &#8220;<\/span><b>misleading advertisement<\/b><span style=\"font-weight: 400;\">&#8221; includes one that falsely describes a product, gives false guarantees, implies an unfair trade practice, or conceals important information.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The guidelines define &#8220;<\/span><b>surrogate advertisement<\/b><span style=\"font-weight: 400;\">&#8221; as one that circumvents a legal prohibition by advertising a permitted product to indirectly promote a prohibited one.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Penalties <\/b><span style=\"font-weight: 400;\">under Section 21 of the Consumer Protection Act, 2019:\u00a0<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Up to Rs 10 lakh for a first violation, and up to Rs 50 lakh for subsequent violations.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">The CCPA can bar an endorser from making any endorsements for up to 1 year (first violation) or up to 3 years (subsequent violations).<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2><b>Past Regulatory History<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">In 2018, the Directorate General of Health Services (DGHS), under the Union Health Ministry, issued show-cause notices to Vishnu Pouch Packaging Pvt Ltd (the brand&#8217;s promoter) under the Cigarettes and Other Tobacco Products Act, 2003, alleging indirect tobacco advertising.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">In January 2024, the Delhi High Court dismissed DGHS&#8217;s appeals, allowing the company to continue advertising its tobacco-free product, while observing that businesses have a &#8220;fundamental right to carry on business&#8221; involving pan masala without tobacco, so long as it has constitutional sanction.<\/span><\/li>\n<\/ul>\n<h2><b>Conclusion<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The Vimal Elaichi case highlights the persistent regulatory challenge of distinguishing genuine product advertising from surrogate promotion of banned substances.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">As Maharashtra tightens enforcement against tobacco products, this episode could set an important precedent for celebrity accountability and brand-endorsement due diligence under India&#8217;s consumer protection framework.<\/span><\/li>\n<\/ul>\n<p><b>Source:<\/b> <a href=\"https:\/\/indianexpress.com\/article\/explained\/vimal-elaichi-ad-fda-notice-srk-surrogate-advertising-10835714\/\" target=\"_blank\" rel=\"nofollow noopener\"><span style=\"font-weight: 400;\">IE<\/span><\/a><span style=\"font-weight: 400;\"> | <\/span><a href=\"https:\/\/www.news18.com\/explainers\/tukaram-singham-mundhes-powers-against-ajay-devgn-shah-rukh-khan-tiger-shroff-in-vimal-elaichi-row-how-did-akshay-kumar-get-out-of-controversy-the-law-surrogate-adverti-ws-kl-10276125.html\" target=\"_blank\" rel=\"nofollow noopener\"><span style=\"font-weight: 400;\">N18<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Surrogate Advertising faces tighter scrutiny in India as regulators examine brand extensions, celebrity endorsements, misleading promotions and advertising of prohibited tobacco products.<\/p>\n","protected":false},"author":18,"featured_media":119732,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[18],"tags":[60,9609,22,59],"class_list":["post-119689","post","type-post","status-publish","format-standard","has-post-thumbnail","category-upsc-mains-current-affairs","tag-mains-articles","tag-surrogate-advertising","tag-upsc-current-affairs","tag-upsc-mains-current-affairs-tag","no-featured-image-padding"],"acf":[],"_links":{"self":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/119689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/comments?post=119689"}],"version-history":[{"count":4,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/119689\/revisions"}],"predecessor-version":[{"id":119735,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/119689\/revisions\/119735"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media\/119732"}],"wp:attachment":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media?parent=119689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/categories?post=119689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/tags?post=119689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}